Trial · NCT07388966
Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia
NCT07388966, Recruiting, SYSNAV
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia. Trials, record NCT07388966. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07388966
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia
- NCT number
- NCT07388966
- Status
- Recruiting
- Enrollment
- 140 participants, estimated
- Lead sponsor
- SYSNAV
- Conditions
- Achondroplasia, Hypochondroplasia
- First posted
- 2026-02-05
- Last updated
- 2026-09-23
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Reliability of digital endpoint derived from Syde® assessed by the Intra-Class Correlation (ICC) for each recording period timepoint. | 12 months | reliability assessed by the ICC (Intra-Class Correlation)for each recording period timepoint (baseline, 6 months, 12 months) |
| Secondary | number of participants reaching 180 hours of recording during the recording periods defined in the protocol | 12 months | Number of patients reaching 180 hours of recordings during the recording periods defined in the protocol (supposed optimal threshold for Syde®-derived digital endpoint computation) at baseline, 6 months, 12 months |
| Secondary | System Usability Score (F-SUS) score at 6 months of Syde® use | 6 months | System Usability Score (SUS) at 6 months. The System Usability Scale is a 10-item questionnaire . It is a simple tool to measure the usability of an interactive system and it is widely used. For each item, the user is asked to express their level of agreement or disagreement from 1 (strongly disagree) and 5 (strongly agree). |
| Secondary | Correlation between digital endpoints derived from Syde® and 6-minutes walk test (6MWT) | 12 months | Correlation at baseline and at different timepoints between Syde® derived digital endpoint and 6MWT |
| Secondary | Correlation between digital endpoints derived from Syde® and growth parameters | 12 months | Correlation at baseline and at different timepoints between Syde® derived digital endpoints and annualized growth velocity, height Z-score, body proportion ratios |
| Secondary | Correlation between digital endpoints derived from Syde® and Patient-reported Outcomes (PROs) | 12 months | Correlation at baseline and at different timepoints between Syde® derived digital endpoints and PROs |
| Secondary | Longitudinal Change in digital endpoints derived from Syde® | 12 months | Change from baseline in digital endpoints derived from Syde® at 6 and 12 months |
| Secondary | Syde® movement reconstruction accuracy compared to Optical Motion Capture measures. | Baseline | Stride detection accuracy of Syde®, stride length and stride velocity accuracy of Syde® and upper limb measures, compared to Optical Motion Capture measures |
| Secondary | Qualitative interview exploring limitations on mobility and impact on daily life | baseline | caregiver and/or participant qualitative interview exploring limitations on mobility daily life |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07388966
GET https://conductscience.org/api/trials/v1/NCT07388966/registered